Kiromic Biopharma, Inc. Quarterly Operating Lease, Liability, Current in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Kiromic Biopharma, Inc. quarterly Operating Lease, Liability, Current history and growth rate from Q1 2022 to Q3 2024.
  • Kiromic Biopharma, Inc. Operating Lease, Liability, Current for the quarter ending September 30, 2024 was $670K, a 8.1% increase year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $670K +$50.2K +8.1% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $656K +$47.2K +7.75% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $642K +$44.8K +7.5% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $631K +$46.6K +7.97% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $620K +$72K +13.1% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $609K +$73.2K +13.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $597K +$117K +24.3% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $584K Dec 31, 2022 10-K 2024-03-19
Q3 2022 $548K Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $536K Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $480K Mar 31, 2022 10-Q 2022-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.